Literature DB >> 23106832

Risk of venous thrombosis in patients with major illnesses: results from the MEGA study.

G Ocak1, C Y Vossen, M Verduijn, F W Dekker, F R Rosendaal, S C Cannegieter, W M Lijfering.   

Abstract

BACKGROUND: The risk of venous thrombosis associated with major illnesses is not well known, and neither is the risk associated with the combined effect of immobilization and thrombophilia. The aim of this study was to assess the effect on the development of venous thrombosis of several major illnesses in combination with immobilization, body mass index, and thrombophilia, to identify high-risk groups that may provide a basis for personalized prevention.
METHODS: This study included 4311 consecutive patients with a first episode of venous thrombosis, and 5768 controls from a case-control study (MEGA study). We calculated odds ratios (ORs) for venous thrombosis for patients with a self-reported history of major illnesses.
RESULTS: Venous thrombosis risk was increased for all investigated major illnesses: liver disease, OR 1.7 (95% confidence interval [CI]1.0-2.9); kidney disease, OR 3.7 (95% CI 2.3-5.9); rheumatoid arthritis, OR 1.5 (95% CI 1.2-1.9); multiple sclerosis, OR 2.4 (95% CI 1.3-4.3); heart failure, OR 1.7 (95% CI 1.2-2.3); hemorrhagic stroke, OR 4.9 (95% CI 2.4-9.9); arterial thrombosis, OR 1.5 (95% CI 1.2-1.8); and the presence of any of the above major illnesses, OR 1.7 (95% CI 1.5-1.9). Combinations of major illnesses with immobilization and increased factor VIII (OR 79.9; 95% CI 33.2-192.2), increased FIX (OR 35.3; 95% CI 14.2-87.8), increased von Willebrand factor (OR 88.0; 95% CI 33.9-228.3), FV Leiden (OR 84.2; 95% CI 19.5-363.6), and blood group non-O (OR 53.1; 95% CI 30.9-91.4) were associated with increased venous thrombosis risks.
CONCLUSIONS: All of the major illnesses reported here were associated with an increased risk of venous thrombosis. These risks were most pronounced at the time of immobilization or in the presence of thrombophilia.
© 2012 International Society on Thrombosis and Haemostasis.

Entities:  

Mesh:

Year:  2013        PMID: 23106832     DOI: 10.1111/jth.12043

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  27 in total

Review 1.  Inherited risk factors for venous thromboembolism.

Authors:  Ida Martinelli; Valerio De Stefano; Pier M Mannucci
Journal:  Nat Rev Cardiol       Date:  2014-01-14       Impact factor: 32.419

2.  Polypharmacotherapy and blood products as risk factors for venous thromboembolism in postsurgical patients: a case-control study.

Authors:  Alenka Premuš Marušič; Daniel Petrovič; Aleš Mrhar; Igor Locatelli
Journal:  Int J Clin Pharm       Date:  2017-03-09

3.  Tuning the Thromboinflammatory Response to Venous Flow Interruption by the Ectonucleotidase CD39.

Authors:  Anuli C Anyanwu; Yogendra Kanthi; Keigo Fukase; Hui Liao; Tekashi Mimura; Karl C Desch; Martin Gruca; Saabir Kaskar; Hussein Sheikh-Aden; Liguo Chi; Raymond Zhao; Vinita Yadav; Thomas W Wakefield; Matthew C Hyman; David J Pinsky
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-04       Impact factor: 8.311

4.  Risk of Pulmonary Embolism After Cerebral Venous Thrombosis.

Authors:  Ava L Liberman; Alexander E Merkler; Gino Gialdini; Steven R Messé; Michael P Lerario; Santosh B Murthy; Hooman Kamel; Babak B Navi
Journal:  Stroke       Date:  2017-02-22       Impact factor: 7.914

Review 5.  Epidemiology of venous thromboembolism in patients with liver diseases: a systematic review and meta-analysis.

Authors:  Xingshun Qi; Weirong Ren; Xiaozhong Guo; Daiming Fan
Journal:  Intern Emerg Med       Date:  2014-12-04       Impact factor: 3.397

6.  Predictors of Deep Venous Thrombosis in Hospitalized Patients With Liver Cirrhosis in the US.

Authors:  Ahmad Abou Yassine; Mohammad Abureesh; Rachelle Hamadi; Loai Dahabra; Mohammad Alshami; Deeb Liliane
Journal:  Cureus       Date:  2022-03-24

Review 7.  Risk of venous thromboembolism in patients with rheumatoid arthritis: a systematic review and meta-analysis.

Authors:  Patompong Ungprasert; Narat Srivali; Ittikorn Spanuchart; Charat Thongprayoon; Eric L Knight
Journal:  Clin Rheumatol       Date:  2014-01-15       Impact factor: 2.980

8.  Gab2 (Grb2-Associated Binder2) Plays a Crucial Role in Inflammatory Signaling and Endothelial Dysfunction.

Authors:  Vijay Kondreddy; Jhansi Magisetty; Shiva Keshava; L Vijaya Mohan Rao; Usha R Pendurthi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-04-08       Impact factor: 8.311

Review 9.  Aspirin and multiple sclerosis.

Authors:  Sheila Tsau; Mitchell R Emerson; Sharon G Lynch; Steven M LeVine
Journal:  BMC Med       Date:  2015-06-29       Impact factor: 8.775

10.  Effect of red blood cell transfusion on inflammation, endothelial cell activation and coagulation in the critically ill.

Authors:  Lisa van Manen; Maike E van Hezel; Margit Boshuizen; Marleen Straat; Angelique M E de Man; Charlotte Dekimpe; Karen Vanhoorelbeke; Robin van Bruggen; Nicole P Juffermans
Journal:  Vox Sang       Date:  2021-07-01       Impact factor: 2.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.